Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Share-based Compensation (2024 - 2025)

Historic Share-based Compensation for Connect Biopharma Holdings (CNTB) over the last 2 years, with Q3 2025 value amounting to $916000.0.

  • Connect Biopharma Holdings' Share-based Compensation fell 5469.83% to $916000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.2 million, marking a year-over-year change of. This contributed to the annual value of $6.7 million for FY2024, which is 2468.5% up from last year.
  • Connect Biopharma Holdings' Share-based Compensation amounted to $916000.0 in Q3 2025, which was down 5469.83% from $951000.0 recorded in Q2 2025.
  • In the past 5 years, Connect Biopharma Holdings' Share-based Compensation registered a high of $2.0 million during Q3 2024, and its lowest value of $916000.0 during Q3 2025.